ABBV - AbbVie Inc.
Eli Lilly has outstanding growth prospects thanks to its leadership in its core therapeutic area. AbbVie's immunosuppressant portfolio helps it to produce steady revenue and profits.
Campbell and CO Investment Adviser LLC purchased a new stake in shares of AbbVie Inc. (NYSE: ABBV) in the third quarter, according to its most recent filing with the SEC. The firm purchased 5,480...
AbbVie has increased its dividend by 333% since 2013. Coca-Cola is a Dividend King that still has plenty of growth potential.
Dividend-paying stocks can be great for investors of any age. The income they deliver can be invested in more shares of stock.
AbbVie's core products have ample growth potential over the next five years. The company also won't face a significant patent cliff in the near future.
Unusual market activity is often the first sign that big changes are coming to a stock. Professional traders and large institutions frequently use the options market to place high-conviction bets...
Guru Stock PicksRichard Pzena has made the following transactions:Add in MBUU by 2.48%Stock News Stocks end flat as chips rally: Taiwan Semiconductor (TSM) and
Based on the topline results from the EPCORE® DLBCL-1 trial, AbbVie along with partner Genmab will engage global regulatory authorities to discuss next steps NORTH CHICAGO, Ill., Jan. 16, 2026...
AbbVie (ABBV) reached $216.75 at the closing of the latest trading day, reflecting a -2.32% change compared to its last close.
These stocks trade at forward earnings multiples of less than 16, well below the S&P 500 average. What's more, their longer-term price-to-earnings-growth ratios are attractive at less than 1.
Elevate Capital Advisors LLC lifted its position in shares of AbbVie Inc. (NYSE: ABBV) by 33.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange...
Conning Inc. lowered its position in AbbVie Inc. (NYSE: ABBV) by 13.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund...
Representative Julia Letlow (R-Louisiana) recently sold shares of AbbVie Inc. (NYSE: ABBV). In a filing disclosed on January 13th, the Representative disclosed that they had sold between $1,001...
Representative Julia Letlow (R-Louisiana) recently bought shares of United Rentals, Inc. (NYSE: URI). In a filing disclosed on January 13th, the Representative disclosed that they had bought...
Representative Julia Letlow (R-Louisiana) recently sold shares of Extra Space Storage Inc (NYSE: EXR). In a filing disclosed on January 13th, the Representative disclosed that they had sold...
Representative Julia Letlow (R-Louisiana) recently bought shares of AstraZeneca PLC (NASDAQ: AZN). In a filing disclosed on January 13th, the Representative disclosed that they had bought between...
Representative Julia Letlow (R-Louisiana) recently sold shares of State Street Corporation (NYSE: STT). In a filing disclosed on January 13th, the Representative disclosed that they had sold...
Representative Julia Letlow (R-Louisiana) recently sold shares of Mettler-Toledo International, Inc. (NYSE: MTD). In a filing disclosed on January 13th, the Representative disclosed that they had...
Representative Julia Letlow (R-Louisiana) recently bought shares of Waters Corporation (NYSE: WAT). In a filing disclosed on January 13th, the Representative disclosed that they had bought between...
Representative Julia Letlow (R-Louisiana) recently bought shares of The Walt Disney Company (NYSE: DIS). In a filing disclosed on January 13th, the Representative disclosed that they had bought...